Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the southwestern United States

Hepatology

Volumn 30, Issue 5, 1999, Pages 1307-1311

  Jamal, M Mazen ^a   Soni, Anurag ^a   Quinn, Patrick G ^a   Wheeler, Donald E ^a   Arora, Sanjeev ^a   Johnston, David E ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; FERRITIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL FEATURE; FEMALE; FERRITIN BLOOD LEVEL; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; MALE; PRIORITY JOURNAL; UNITED STATES; VIRUS LOAD;

ADULT; ALANINE TRANSAMINASE; BILIRUBIN; CASE-CONTROL STUDIES; CONTINENTAL POPULATION GROUPS; FEMALE; FERRITINS; HEPATITIS C, CHRONIC; HUMANS; INFLAMMATION; IRON; LIVER; MALE; REFERENCE VALUES; RNA, VIRAL; SERUM ALBUMIN; SEX CHARACTERISTICS; SOUTHWESTERN UNITED STATES;

EID: 0032714315     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300526     Document Type: Article

References (31)

1. Alter MJ, Marcolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, et al. The natural history of community acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-1905.
2. Datz C, Cramp M, Haas T, Dietze O, Nitschko H, Froesner G, Muss N, et al. The nátural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre. Gut 1999;44:563-567.
3. Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. HEPATOLOGY 1997;26(Suppl):34S-38S.
4. Fattovich G. Progression of hepatitis B and C to hepatocellular carcinoma in Western countries. Hepatogastroenterology 1998;45:1206-1213.
5. Urdea MS, Wuestehube LJ, Laurenson PM, Wilber JC. Hepatitis C- diagnosis and monitoring. Clin Chem 1997;43:1507-1511.
6. Gretch DR. Diagnostic tests for hepatitis C. HEPATOLOGY 1997;26(Suppl): 43S-47S.
7. Inglesby TV, Rai R, Astemborski J, Gruskin L, Nelson KE, Vlahov D, Thomas DL. A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use. HEPATOLOGY 1999;29:590-596.
8. Seeff LB. Natural history of hepatitis C. HEPATOLOGY 1997;26(Suppl):21S-28S.
9. Tassopoulos NC. Patterns of progression: unpredictability and risk of decompensated cirrhosis. Dig Dis Sci 1996;41(Suppl):41S-48S.
10. Gretch DR. Use an interpretation of HCV diagnostic tests in the clinical setting. In Gitlin N, Davis GL, eds. Clinics in Liver Disease,Volume 1. Philadelphia: Saunders 1997;543-557.
11. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74:2391-2399.
12. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. HEPATOLOGY 1994;19:1513-1520.
13. Ishak K, Baptista L, Bianchi L, Callea F, DeGroote J, Gudat F, Denk H, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699.
14. Stanley AJ, Haydon GH, Piris J, Jarvis LM, Hayes PC. Assessment of liver histology in patients with hepatitis C and normal transaminase levels. Eur J Gastroenterol Hepatol 1996;8:869-872.
15. Mathurin P, Moussalli J, Cadranel JF, Thibault V, Charlotte F, Dumouchel P, Cazier A, et al. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. HEPATOLOGY 1998;27:868-872.
16. Puoti C, Magrini A, Stati T, Rigato P, Montagnese F, Rossi P, Aldegheri L, et al. Clinical, histological and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. HEPATOLOGY 1997;26:1393-1398.
17. Prati D, Capelli C, Zanella A, Mozzi F, Bosoni P, Pappalettera M, Zanuso F, et al. Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection. Gastroenterology 1996;110:178-183.
18. Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, Belloni G, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. HEPATOLOGY 1995;21:285-290.
19. Gretch D, Corey L, Wilson J, dela Rosa C, Willson R, Carithers R Jr, Busch M, et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease. J Infect Dis 1994;169: 1219-1225.
20. Hagiwara H, Hayashi N, Fusamoto H, Kamada T. Quantitative analysis of hepatitis C virus RNA: relationship between the replicative level and the various stages of the carrier states or the response to interferon therapy. Gastroenterol Jpn 1993;28:48-51.
21. Lau JY, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993;341:1501-1504.
22. Jeffers LJ, Dailey PJ, Coelho-Little E, de Medina M, Scott C, La Rue S, Hill M, et al. Correlation of HCV RNA quantitation in sera and liver tissue of patients with chronic hepatitis C [Abstact]. Gastroenterology 1993;106:A923.
23. Arber N, Konikoff FM, Moshkowitz M, Baratz M, Hallak A, Santo M, Halpern Z, et al. Increased serum iron and iron saturation without iron accumulation distinguish chronic hepatitis C from other chronic liver diseases. Dig Dis Sci 1994;39:2656-2659.
24. Sartori M, Andorno S, La Terra G, Boldorini R, Leone F, Pittau S, Zecchina G, et al. Evaluation of iron status in patients with chronic hepatitis C. Ital J Gastroenterol Hepatol 1998;30:396-401.
25. Caramelo C, Albalate M, Bermejillo T, Navas S, Ortiz A, de Sequera P, Casado S, et al. Relationships between plasma ferritin and aminotransferase profile in haemodialysis patients with hepatitis C virus. Nephrol Dial Transplant 1996;11:1792-1796.
26. Olsson KS, Ritter B, Lundin PM. Liver affection in iron overload studied with serum ferritin and serum aminotransferases. Acta Med Scand 1985;217:79-84.
27. Gholson CF, Kelly M, Catinis G, Favrot D, Taylor B, Gonzalez E, Balart L. Chronic hepatitis C with normal aminotransferase levels: a clinical histologic study. Am J Gastroenterol 1997;92:1788-1792.
28. Seeff LB. The natural history of chronic hepatitis C virus infection. In: Gitlin N, Davis GL, eds. Clinics in Liver Disease. Volume 1. Philadelphia: Saunders 1997;587-602.
29. Gordon SC, Elloway RS, Long JC, Dmuchowski CF. The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs intravenous drug use. HEPATOLOGY 1993;18:1338-1343.
30. Tong MJ, El-Farra NS, Reikes AR, Lo RL. Clinical outcomes after transfusion associated hepatitis C. N Engl J Med 1995;332:1463-1466.
31. Gordon SC, Bayati N, Silverman AL. Clinical outcome of hepatitis C as a function of mode of tranmission. HEPATOLOGY 1998;28:562-567.